AR096552A1 - Compuesto de amida heterocíclica aromática que contiene nitrógeno bicíclico - Google Patents

Compuesto de amida heterocíclica aromática que contiene nitrógeno bicíclico

Info

Publication number
AR096552A1
AR096552A1 ARP140102215A ARP140102215A AR096552A1 AR 096552 A1 AR096552 A1 AR 096552A1 AR P140102215 A ARP140102215 A AR P140102215A AR P140102215 A ARP140102215 A AR P140102215A AR 096552 A1 AR096552 A1 AR 096552A1
Authority
AR
Argentina
Prior art keywords
lower alkyl
halogen
amida
same
compound containing
Prior art date
Application number
ARP140102215A
Other languages
English (en)
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of AR096552A1 publication Critical patent/AR096552A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Se provee un compuesto que es útil como un agente para el tratamiento de cáncer de mama. Reivindicación 1: Un compuesto de la fórmula (1) o una de sus sales, en la fórmula, R¹ es arilo o heteroarilo que contiene nitrógeno monocíclico, cada uno de los cuales puede estar sustituido con grupos seleccionados del grupo que consiste en halógeno, alquilo inferior, -O-alquilo inferior, halógeno-alquilo inferior, -O- halógeno-alquilo inferior, -CN, dimetilamino y cicloalquilo; X es CH, N o C; ⁻ ⁻ ⁻ ⁻ ⁻ es i) un enlace simple en el caso donde X es CH o N y ii) un enlace doble en el caso donde X es C; Y es un grupo cíclico seleccionado del grupo de fórmulas (2) aquí, Y¹ es CRʰ o N; Y² es CRⁱ o N, siempre que Y¹ e Y² no sean N al mismo tiempo; Rᵃ, Rʰ y Rⁱ, que son iguales o diferentes entre sí, son H o halógeno; Rᵇ es H o alquilo inferior; Rᶜ es alquilo inferior; Y³ es CH o N; Rᵈ y Rᵉ son iguales o diferentes entre sí, son H, halógeno, alquilo inferior; Rᶠ es H o alquilo inferior; Y⁴ es O ó S; Y⁵ es CH o N; Y⁶ es CH o N; Rᵍ es H o alquilo inferior; R² es H o alquilo inferior; y R³ y R⁴, que son iguales o diferentes entre sí, son H, halógeno, alquilo inferior -O-alquilo inferior, halógeno-alquilo inferior, -O-halógeno-alquilo inferior cicloalquilo, o -CN, o R³ y R⁴ pueden formar 2,2-difluoro-1,3-benzodioxol mediante la unión entre sí con el anillo benceno al cual R³ y R⁴ están enlazados.
ARP140102215A 2013-06-10 2014-06-09 Compuesto de amida heterocíclica aromática que contiene nitrógeno bicíclico AR096552A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013122180 2013-06-10

Publications (1)

Publication Number Publication Date
AR096552A1 true AR096552A1 (es) 2016-01-13

Family

ID=52022229

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP140102215A AR096552A1 (es) 2013-06-10 2014-06-09 Compuesto de amida heterocíclica aromática que contiene nitrógeno bicíclico

Country Status (21)

Country Link
US (1) US9428501B2 (es)
EP (1) EP3009424B1 (es)
JP (1) JP5924453B2 (es)
KR (1) KR20160018686A (es)
CN (1) CN105308024B (es)
AR (1) AR096552A1 (es)
AU (1) AU2014279240A1 (es)
BR (1) BR112015030248A2 (es)
CA (1) CA2914982A1 (es)
EA (1) EA028545B1 (es)
ES (1) ES2661259T3 (es)
HK (1) HK1220446A1 (es)
IL (1) IL242997A (es)
MX (1) MX2015016965A (es)
PH (1) PH12015502744A1 (es)
PL (1) PL3009424T3 (es)
PT (1) PT3009424T (es)
SA (1) SA515370253B1 (es)
SG (1) SG11201510125WA (es)
TW (1) TW201536771A (es)
WO (1) WO2014199933A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015338042A1 (en) 2014-10-28 2017-04-27 Shionogi & Co., Ltd. Heterocyclic derivative having AMPK activating effect
US20170360781A1 (en) * 2014-12-09 2017-12-21 Astellas Pharma Inc. Pharmaceutical composition comprising bicyclic nitrogen-containing aromatic heterocyclic amide compound as active ingredient
MA41158A (fr) * 2014-12-09 2017-10-17 Astellas Pharma Inc Composition pharmaceutique comprenant un composé d'amide hétérocyclique aromatique contenat de l'azote bicyclique en tant que principe actif
MA41157A (fr) * 2014-12-09 2017-10-17 Astellas Pharma Inc Composition pharmaceutique comprenant un composé d'amide hétérocyclique aromatique contenant de l'azote bicyclique en tant que composant actif
EP3455207A4 (en) * 2016-05-12 2019-10-09 Regents of the University of Minnesota INDOL AND INDAZOCYANOCINNAMATE COMPOUNDS AND THERAPEUTIC USES THEREOF

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19932314A1 (de) * 1999-07-10 2001-01-11 Merck Patent Gmbh Benzofuranderivate
WO2002020008A1 (en) 2000-09-06 2002-03-14 The Scripps Research Institute Inhibitors of nadh:ubiquinone oxidoreductase
WO2007110364A1 (en) * 2006-03-28 2007-10-04 High Point Pharmaceuticals, Llc Benzothiazoles having histamine h3 receptor activity
US7432255B2 (en) * 2006-05-16 2008-10-07 Hoffmann-La Roche Inc. 1H-indol-5-yl-piperazin-1-yl-methanone derivatives
US8003649B2 (en) * 2007-12-21 2011-08-23 Astrazeneca Ab Bicyclic derivatives for use in the treatment of androgen receptor associated conditions-155
JP5420566B2 (ja) * 2007-12-21 2014-02-19 スリーエム イノベイティブ プロパティズ カンパニー 微生物系及び流体試料分析の方法
CN102099357B (zh) * 2008-04-23 2014-07-02 里格尔药品股份有限公司 用于治疗代谢障碍的甲酰胺化合物
KR101764952B1 (ko) * 2010-07-29 2017-08-03 리겔 파마슈티칼스, 인크. Ampk-활성화 헤테로시클릭 화합물 및 그의 사용 방법
WO2013116491A1 (en) 2012-02-01 2013-08-08 Rigel Pharmaceuticals, Inc. Carboxamide, sulfonamide and amine compounds and methods for using them

Also Published As

Publication number Publication date
EP3009424A4 (en) 2016-11-30
EA201592301A1 (ru) 2016-05-31
SA515370253B1 (ar) 2017-03-06
BR112015030248A2 (pt) 2017-07-25
IL242997A (en) 2017-04-30
EP3009424A1 (en) 2016-04-20
PH12015502744A1 (en) 2016-03-21
ES2661259T3 (es) 2018-03-28
US20150266869A1 (en) 2015-09-24
JPWO2014199933A1 (ja) 2017-02-23
CA2914982A1 (en) 2014-12-18
PL3009424T3 (pl) 2018-03-30
EP3009424B1 (en) 2017-12-20
CN105308024B (zh) 2017-10-27
KR20160018686A (ko) 2016-02-17
WO2014199933A1 (ja) 2014-12-18
MX2015016965A (es) 2016-04-25
JP5924453B2 (ja) 2016-05-25
US9428501B2 (en) 2016-08-30
PT3009424T (pt) 2018-01-16
TW201536771A (zh) 2015-10-01
AU2014279240A1 (en) 2016-01-07
HK1220446A1 (zh) 2017-05-05
CN105308024A (zh) 2016-02-03
EA028545B1 (ru) 2017-11-30
SG11201510125WA (en) 2016-01-28

Similar Documents

Publication Publication Date Title
AR106763A1 (es) Oxadiazoles sustituidos para combatir hongos fitopatógenos
AR099995A1 (es) Piridilamidinas fungicidas
AR106605A1 (es) Oxadiazoles sustituidos para combatir hongos fitopatógenos
AR096552A1 (es) Compuesto de amida heterocíclica aromática que contiene nitrógeno bicíclico
AR095311A1 (es) 3-pirimidin-4-il-oxazolidin-2-onas como inhibidores de idh mutante
CR20170564A (es) Nuevos derivados hidroxiéster, un proceso para su preparación y composiciones farmacéuticas que los contienen
AR100645A1 (es) Derivados de pirazolo-pirimidina
AR095326A1 (es) Heterociclos tricíclicos como inhibidores de la proteína bet
AR080057A1 (es) Piridinas disustituidas como anticancerigenos
AR090760A1 (es) Compuestos de benzotiazol y su uso contra el virus de hiv
SV2017005405A (es) Compuestos y composiciones como inhibidores de quinasa raf
AR097325A1 (es) Pirroles anillados
AR100315A1 (es) Compuestos de piridina sustituida que tienen acción herbicida
AR111983A1 (es) ANILLOS 6 - 5 FUSIONADOS COMO INHIBIDORES DE C5a
AR093825A1 (es) COMPUESTOS CON ACTIVIDAD ANTAGONISTA DE LOS RECEPTORES MUSCARINICOS Y ACTIVIDAD AGONISTA DEL RECEPTOR b2 ADRENERGICO
CO2018003367A2 (es) Benzamidas sustituidas con isoxazolina y análogos como insecticidas
AR092170A1 (es) Proceso para la fabricacion de benzoxazinonas
AR089753A1 (es) Derivados de amida heterociclicos como antagonistas del receptor p2x7
PE20160880A1 (es) Compuestos de triazolona y usos de los mismos
AR105549A1 (es) Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo y usos de los mismos
AR097932A1 (es) Antagonista del receptor de somatostatina del subtipo 5 (sstr5)
AR098818A1 (es) Derivados de oxindol, preparación de los mismos y uso terapéutico de los mismos
SV2016005293A (es) Compuestos de azol amido-sustituidos como inhibidores de tnks1 y/o tnks2
DOP2014000178A (es) Nuevos derivados de bencil sulfonamida útiles como inhibidores de mogat-2
CU24248B1 (es) Derivados de (piperidin-4-il)piperazina-1-carboxamida/carboxilato como antagonistas del receptor-h3

Legal Events

Date Code Title Description
FB Suspension of granting procedure